Analysis of clinical treatment programs for children with Juvenile idiopathic arthritis -with 104 ca

来源 :中华医学生物免疫学会第二届学术年会 | 被引量 : 0次 | 上传用户:xnlpktg
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective Investigate the clinical treatment program of children with systemic onset juvenile idiopathic arthritis (So-JIA) and its efficacy analysis.Methods Retrospective analysis of the clinical treatment program and its efficacy of SO-JIA patients hospitalized in the Guangzhou Women and Childrens Medical Center in recent years.
其他文献
Objective To investigate the value of antikeration antibody (AKA),anti-cyclic citrullinated peptide antibody (antiCCP) and rheumatoid factor (RF-IgG,RF-IgM) in early diagnosis and prediction of juveni
Objective:Investigate the relationship between immunological parameters AKA,anti-CCP,the RF-IGG,RF-IGM and the early diagnosis and prognosis in sub-JIA patients.Methods:Collection of 76 JIA patients i
Objective:Research the Recombinant Human Tumor Necrosis Factor-α Receptor type Ⅱ fusion protein antibody (Etanercept)for Treatment of juvenile idiopathic arthritis (JIA).A randomized double-blind cont
objective :The randomized method was designed to observe the efficacy and safety ofinfliximab for juvenile idiopathic arthritis (JIA) and juvenile ankylosing spondylitis (JAS).This study will provide
Objective:Using the ACR Ped-30,50,70 to assess the clinical efficacy of tumor necrosis factor antagonist in refractory systemic juvenile idiopathic arthritis (So-JIA).Methods:Evaluate the 30 refractor
Objective:To investigate the 9th chromosome abnormalities and the incidence of JRA and other autoimmune diseases genetic factors.Methods:Report 1 chromosomal disorder case merger JRA in our hospital a
会议
Objective:To investigates the distribution of CD 14 promoter gene-C-159T polymorphism in Guangdong Han population of China and analyzes the association of CD 14 polymorphisms with juvenile idiopathic
Objective:To discuss the clinical efficacy and safety of the biological agents Etanercept (Enbrel) for the treatment of two cases of children with antineutrophil cytoplasmic antibody associated vascul
会议
Objective:To discuss the clinical efficacy and safety of the biological agents Etanercept (Enbrel) for the treatment of three cases of intractable juvenile idiopathic arthritis (JIA).Methods:There are
会议
Objective To analyze the clinical features and genetic diagnosis of 138 cases of primary immunodeficiency(PID).Improve the understanding of the pediatrician of the disease.Methods Retrospective analys